Purchases and Sales Made in Q1 2025 in Pharma Cyte Biotech, Inc. (PMCB)
This table provides information about the institutional ownership of Pharma Cyte Biotech, Inc. (PMCB) during Q1 2025. The information is specifically focused on institutions that hold shares of PharmaCyte Biotech, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 13, 2025
Q1 2025
|
Ubs Group Ag
|
BUY
|
- |
10K+ 535.86% |
$12.6K - $18.7K
|
11.9K
$12K
|
|
|
May 12, 2025
Q1 2025
|
National Bank Of Canada
|
BUY
|
- |
3.3KNew |
$4.13K - $6.14K
|
3.3K
$3.33K
|
|
|
May 09, 2025
Q1 2025
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
2.13K+ 1.11% |
$2.66K - $3.96K
|
195K
$196K
|
|
|
May 15, 2025
Q1 2025
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
993+ 40.61% |
$1.24K - $1.85K
|
3.44K
$3.47K
|
|
|
May 14, 2025
Q1 2025
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
200+ 0.41% |
$250 - $372
|
49.5K
$50K
|
|
|
May 05, 2025
Q1 2025
|
Ifp Advisors, Inc
|
BUY
|
- |
1New |
$1.25 - $1.86
|
1
$1.01
|
|
|
May 14, 2025
Q1 2025
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1- 50.0% |
$1.25 - $1.86
|
1
$1.01
|
|
|
May 12, 2025
Q1 2025
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2- 11.11% |
$2.5 - $3.72
|
16
$16.2
|
|
|
May 15, 2025
Q1 2025
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-5- 6.41% |
$6.25 - $9.3
|
73
$73.7
|
|
|
May 15, 2025
Q1 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-200- 0.78% |
$250 - $372
|
25.5K
$25.8K
|
|
|
May 12, 2025
Q1 2025
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-498- 98.03% |
$623 - $926
|
10
$10.1
|
|
|
May 13, 2025
Q1 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-6.54K- 24.37% |
$8.18K - $12.2K
|
20.3K
$20.5K
|
|
|
May 14, 2025
Q1 2025
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-16.1K- 46.62% |
$20.1K - $29.9K
|
18.4K
$18.6K
|
|
|
May 13, 2025
Q1 2025
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-25.8K- 15.66% |
$32.3K - $48K
|
139K
$140K
|